Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy & Safety of Flutiform vs Fluticasone + Formoterol in Asthma
NCT00563056Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Sep 2007
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
Phase 3, randomised, open-label trial of fluticasone propionate + formoterol in asthma (2 arms), sponsored by Mundipharma. Primary endpoint: Forced Expiratory Volume in 1 second at 12 weeks. Started Sep 2007; status: completed.
02
Drugs
fluticasone propionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00563056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00563056.